Description
- Qanti® Breast ER/PR is designed to assist anatomic pathologists in the quantitative cell counts and semi-quantitative Allred score interpretation of ER/PR IHC status in breast cancer.
Scoring System
- Allred score (Proportion score, Intensity score)
Performance
- F1-score > 90%
Certified by MFDS(K-FDA)
Qanti® Breast ER, PR, HER2, and Ki-67 modules have been approved as 'Qanti® IHC' by the Korean Ministry of Food and Drug Safety.
